AFM
CANF

Anson Funds Management’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Anson Funds Management’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-453
Closed -$1.96M – 28
2018
Q1 		$1.96M Buy
+453
New +$2.5M 1.46% 11

Other funds holding CANF

TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return
AF
Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Anson Funds Management's CANF Position: Q2 2018 in Review

Anson Funds Management sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q2 2018, closing a stake of 453 shares — an estimated $1.96M sold.

Anson Funds Management first reported a position in CANF in Q1 2018 and held it in 1 quarter. The position peaked at $1.96M in Q1 2018. 11 funds tracked by Wall St. Rank hold CANF as of Q2 2018.

  • Anson Funds Management reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q2 2018 after selling out during the quarter.
  • Anson Funds Management sold 453 Can-Fite BioPharma American Depositary Shares shares in Q2 2018, an estimated $1.96M.
  • Anson Funds Management first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2018 and held it in 1 quarter.
  • Anson Funds Management's Can-Fite BioPharma American Depositary Shares position peaked at $1.96M in Q1 2018.
  • 11 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2018.

Based on Anson Funds Management's 13F filing for Q2 2018, filed 14 Aug 2018.